Login / Signup

Should high risk smoldering myeloma be treated outside a clinical trial: NO.

Morie A GertzIuliana Vaxman
Published in: Leukemia & lymphoma (2021)
Keyphrases
  • clinical trial
  • newly diagnosed
  • multiple myeloma
  • phase ii
  • open label
  • study protocol
  • double blind
  • phase iii
  • randomized controlled trial